CLINICAL_TRIALS
trial_result
· 2018-01-23
Clinical Trial Update: A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML) [Phase 2]
Summary
A Phase 2 trial of venetoclax (ABT-199) in patients with acute myeloid leukemia has completed enrollment with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie | Conditions: Acute Myelogenous Leukemia, AML | Phase 2 | Status: COMPLETED | Results posted: 2018-01-23